Skip to content
  • twitter
  • linkedin
  • onxeo
  • SUBSCRIBE TO OUR NEWS
  • EN
  • FR
  • CONTACT
Onxeo

Onxeo

Onxeo designs and develops novel oncology drugs targeting tumor DNA repair functions.

  • COMPANY
    • Profile
    • Management
    • Board of Directors
    • Join us
    • Contact us
  • SCIENCE
    • Scientific Advisory Committee
    • DNA Damage Response
    • platON™
    • Collaborations
  • PRODUCTS
    • DDR Pipeline
    • AsiDNA™
    • OX401
    • Other
  • INVESTORS
    • Regulated Information
      • Press Releases
      • Registration documents
      • Financial Information
      • Shares & Voting Rights
      • Share Repurchase/ Liquidity Agreement
      • Financial operations
      • Sponsor/ Advisor
    • Governance
      • Board Committees & Regulations
      • Directors’ Disclosures
      • Bylaws
    • Shareholder Resources
      • General Meetings
      • Financial Calendar
      • Stock Information
      • Shareholders’ Letters
    • Investor Relations
  • NEWS & EVENTS
    • Press Releases
    • Events & Presentations
    • Shareholder Letters
    • Media

Category: Media

Le Journal des Biotechs | Interview of Shefali Agarwal, President and CEO of Onxeo

04/20/202205/02/2022

Watch the interview (in French)

B-Smart – Interview of Judith Greciet, CEO of Onxeo

03/26/2021

Watch the interview (in French)

Edison TV – Interview of Judith Greciet, CEO of Onxeo

12/15/202001/04/2021

www.edisongroup.com

Le Journal des Biotechs – Entretien avec Judith Greciet

12/02/202012/03/2020

Read the interview

Boursorama – Judith Greciet, Onxeo : «AsiDNA could open a new paradigm in cancer treatment»

06/17/202012/02/2020

  Read the interview  

Onxeo offre 10,7% de son capital à Invus – Biotech Finances

06/15/202006/15/2020

(French only) Regards croisés : Interviews of Judith Greciet, CEO of Onxeo, and Mr Nicolas Trebouta, representing Financière de la […]

BFM Business Intégrale Bourse : Onxeo, Company of the Day

06/10/202006/11/2020

  Interview of Judith Greciet, CEO of Onxeo, following the entry into the capital of Invus, a long-term renowned investor […]

“La France bouge” – Europe 1 : Interview of Judith Greciet

02/04/202003/13/2020

(in French only)   Watch the interview  

LesEchos/Investir–Presentation of Judith Greciet at Direct Dirigeants event

11/06/201903/13/2020

(in French only)

LE QUOTIDIEN DU MÉDECIN – Un candidat médicament innovant qui détourne les mécanismes de réparation de l’ADN tumoral

03/29/201912/16/2019

  Read the article in Le Quotidien du Médecin (in French)  

BFM BOURSE – Onxeo : Vers la réparation de l’ADN des cellules tumorales

03/01/201610/08/2019

  Read more on BFM Bourse (in French)  

LES ECHOS – Onxeo veut contrer la réparation de l’ADN des cellules tumorales

03/02/201610/08/2019

  Read the article in Les Echos (in French)  

CANCER RESEARCH NEWS – A new cancer combination

11/16/201610/08/2019

  Read the article in Cancer Research News    

LA TRIBUNE – Cancer : Onxeo vise une nouvelle stratégie thérapeutique pour “contenir l’évolution de la maladie”

02/07/201710/08/2019

Read the article in  La Tribune (in French)  

CLINICAL LEADER – The Science Of M&A: Making The Most Of Your Financial Resources

02/16/201710/08/2019

  Read the article on clinicalleader.com  

LA BOURSE ET LA VIE – Entretien avec Nicolas Fellmann, Directeur Financier

10/12/201810/08/2019

  Watch the interview on La Bourse et la Vie.com (in French)  

LES ECHOS/ INVESTIR – Présentation de Judith Greciet, Directrice générale au BoursoCap Event

11/21/201810/08/2019

  Watch CEO Judith Greciet’s presentation (French only) https://vimeo.com/304376654  

EDISON TV – Interview of CEO Judith Greciet

01/04/201809/13/2019

Watch video on Edison TV

NEWS & EVENTS

  • Press Releases
  • Events & Presentations
  • Shareholder Letters
  • Media
Onxeo

> SITE MAP

> LEGAL NOTICES
> FOLLOW US

COMPANY

COMPANY


  • Profile
  • Executive Committee
  • Board of Directors
  • Join us
  • Contact us

SCIENCE

SCIENCE


  • DNA Damage Response
  • platON™
  • Collaborations

PRODUCTS

PRODUCTS


  • Pipeline
  • AsiDNA™
  • OX401
  • belinostat / Beleodaq®

INVESTORS

INVESTORS


  • Regulated Information
  • Governance
  • Shareholder Resources
  • Investor Relations

NEWS AND EVENTS

NEWS & RELEASES


  • Press Releases
  • Events & Presentations
  • NewsLetters
  • Media
SUBSCRIBE TO
OUR NEWS
CONTACT
US

ONXEO SA


49, avenue du Général Martial Valin
75015 PARIS – FRANCE
+33 (0) 1 45 58 76 00

185 Alewife Brook Parkway
Suite 210, Cambridge, MA 02138
(617) 648-8674

© Copyright 2019 Onxeo
Photos : Onxeo - Design : 1sur1.net

Copyright © 2023 Onxeo All rights reserved. Theme: Flash by ThemeGrill. Powered by WordPress